Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Receivables - Other: 2009-2024

Historic Receivables - Other for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $117.9 million.

  • Fresenius Medical Care AG's Receivables - Other fell 5353.65% to $116.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $755.2 million, marking a year-over-year increase of 98.72%. This contributed to the annual value of $117.9 million for FY2024, which is 5293.9% down from last year.
  • According to the latest figures from FY2024, Fresenius Medical Care AG's Receivables - Other is $117.9 million, which was down 5293.9% from $250.5 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Receivables - Other ranged from a high of $250.5 million in FY2023 and a low of $104.4 million during FY2020
  • Its 5-year average for Receivables - Other is $173.6 million, with a median of $185.7 million in 2021.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Receivables - Other skyrocketed by 7790.57% in 2021, and later crashed by 5293.9% in 2024.
  • Annual analysis of 5 years shows Fresenius Medical Care AG's Receivables - Other stood at $104.4 million in 2020, then skyrocketed by 77.91% to $185.7 million in 2021, then grew by 12.67% to $209.3 million in 2022, then rose by 19.72% to $250.5 million in 2023, then crashed by 52.94% to $117.9 million in 2024.
  • Its Receivables - Other was $117.9 million in FY2024, compared to $250.5 million in FY2023 and $209.3 million in FY2022.